---
title: "AKS, Anti-Kickback Statute | MedTech Terms"
description: "U.S. criminal statute prohibiting remuneration to induce federal healthcare business. Plain-English Commercialization definition for MedTech teams, with example"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/anti-kickback#term",
        "name": "Anti-Kickback Statute",
        "alternateName": "AKS",
        "description": "The Anti-Kickback Statute (42 USC §1320a-7b) makes it a criminal offense to knowingly offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by federal healthcare programs. Safe harbors define protected arrangements.",
        "url": "https://medtechterms.com/terms/anti-kickback",
        "termCode": "anti-kickback",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/anti-kickback#article",
        "headline": "AKS, Anti-Kickback Statute",
        "description": "U.S. criminal statute prohibiting remuneration to induce federal healthcare business.",
        "url": "https://medtechterms.com/terms/anti-kickback",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/anti-kickback"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/anti-kickback#term"
        },
        "articleSection": "Commercialization",
        "inLanguage": "en",
        "keywords": "Anti-Kickback Statute, AKS, Commercialization, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "OIG AKS",
            "url": "https://oig.hhs.gov/compliance/physician-education/fraud-abuse-laws/",
            "publisher": {
              "@type": "Organization",
              "name": "HHS OIG"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "AdvaMed Code of Ethics",
            "url": "https://www.advamed.org/our-work/code-of-ethics/",
            "publisher": {
              "@type": "Organization",
              "name": "AdvaMed"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "AHRMM - Healthcare Supply Chain",
            "url": "https://www.ahrmm.org/",
            "publisher": {
              "@type": "Organization",
              "name": "AHRMM"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/sunshine-act#term",
            "name": "Physician Payments Sunshine Act",
            "url": "https://medtechterms.com/terms/sunshine-act"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/stark-law#term",
            "name": "Stark Law",
            "url": "https://medtechterms.com/terms/stark-law"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Commercialization",
            "item": "https://medtechterms.com/terms?cat=Commercialization"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Anti-Kickback Statute",
            "item": "https://medtechterms.com/terms/anti-kickback"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/anti-kickback#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "What is the primary purpose of the Anti-Kickback Statute?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The primary purpose of the AKS is to protect patients and federal healthcare programs from fraud and abuse by preventing arrangements that could lead to overutilization, increased costs, or steering patients to particular providers for financial gain rather than medical necessity."
            }
          },
          {
            "@type": "Question",
            "name": "What are safe harbors in the context of the AKS?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Safe harbors are regulatory exceptions that protect certain business practices and financial relationships from AKS prosecution if all specified conditions are met, ensuring these arrangements are legitimate and do not pose a risk of fraud or abuse."
            }
          },
          {
            "@type": "Question",
            "name": "Who enforces the Anti-Kickback Statute?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The Anti-Kickback Statute is primarily enforced by the Department of Justice (DOJ) and the Office of Inspector General (OIG) within the Department of Health and Human Services (HHS)."
            }
          },
          {
            "@type": "Question",
            "name": "Can violations of the AKS result in criminal penalties?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Yes, violations of the AKS can result in severe criminal penalties, including fines, imprisonment, and exclusion from participation in federal healthcare programs, as well as civil monetary penalties."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Commercialization](/terms?cat=Commercialization)
6.  /
7.  Anti-Kickback Statute

[All terms](/terms)

Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)AKS 

# Anti-Kickback Statute

U.S. criminal statute prohibiting remuneration to induce federal healthcare business.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

The Anti-Kickback Statute (42 USC §1320a-7b) makes it a criminal offense to knowingly offer, pay, solicit, or receive remuneration to induce or reward referrals of items or services payable by federal healthcare programs.  [Safe](/terms/safe-note) harbors define protected arrangements. 

What the regulation says

The Anti-Kickback Statute (AKS) prohibits the exchange of anything of value (remuneration) to induce or reward patient referrals or generate business involving any item or service payable by a federal health care program, as outlined in 42 U.S.C. §1320a-7b. The Office of Inspector General (OIG) provides guidance and publishes " [safe](/terms/safe-note) harbor" regulations that protect certain arrangements from AKS prosecution, provided specific conditions are met. 

## What this means in practice

AKS shapes nearly every MedTech commercial program - physician consulting, training grants,  [KOL](/terms/kol) engagement, product loans,  [GPO](/terms/gpo) contracting. Violations carry criminal, civil, and exclusion penalties. 

## Examples

-   A MedTech company provides consulting fees to a physician for legitimate services, documented at fair market value and separate from any referral volume, fitting within a safe harbor.
-   A medical device manufacturer offers free training and education to clinicians on the safe and effective use of its devices, which can be permissible if not tied to referrals or purchases.
-   A MedTech company partners with hospitals to provide devices for clinical trials, structured to comply with research exemptions and not to induce referrals.

Common pitfalls

-   • Misinterpreting safe harbor provisions can lead to non-compliance, as strict adherence to all conditions is required for protection. 
-   • Assuming that an arrangement is permissible simply because it is common practice in the industry is a significant pitfall. 
-   • Failing to properly document the fair market value and legitimate business purpose of all remuneration can lead to scrutiny and potential violations. 
-   • Not understanding the broad definition of "remuneration" beyond direct payments, which can include gifts, free services, or excessive compensation, is a common mistake. 
-   • Neglecting to consider state anti-kickback laws, which may impose stricter requirements than the federal AKS, can result in legal issues. 

## Frequently asked questions

What is the primary purpose of the Anti-Kickback Statute? 

The primary purpose of the AKS is to protect patients and federal healthcare programs from fraud and abuse by preventing arrangements that could lead to overutilization, increased costs, or steering patients to particular providers for financial gain rather than medical necessity. 

What are safe harbors in the context of the AKS? 

Who enforces the Anti-Kickback Statute? 

Can violations of the AKS result in criminal penalties? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Commercialization

Physician Payments Sunshine Act

U.S. law requiring disclosure of payments to physicians and teaching hospitals.





](/terms/sunshine-act)[

Commercialization

Stark Law

Federal law restricting physician self-referral for designated health services.





](/terms/stark-law)

### More in Commercialization

· Same category 

[

Commercialization

AdvaMed Code of Ethics

Industry code governing interactions between U.S. medical-device companies and healthcare professionals.





](/terms/advamed-code)[

Commercialization

Advisory Board

Convening of external experts to advise on strategy or product.





](/terms/advisory-board)[

Commercialization

Bottom-Up Market Sizing

Building market size from procedure volumes × price × penetration.





](/terms/bottom-up-sizing)[

Commercialization

Distributor vs Direct Sales

Choice between selling through third-party distributors or hiring a direct salesforce.





](/terms/distributor-direct)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

HHS OIG· 1 AdvaMed· 1 AHRMM· 1 

1.  [1 
    
    OIG AKS
    
    Verified 
    
    HHS OIG · oig.hhs.gov 
    
    
    
    ](https://oig.hhs.gov/compliance/physician-education/fraud-abuse-laws/)
2.  [2 
    
    AdvaMed Code of Ethics
    
    Verified 
    
    AdvaMed · advamed.org 
    
    
    
    ](https://www.advamed.org/our-work/code-of-ethics/)
3.  [3 
    
    AHRMM - Healthcare Supply Chain
    
    Verified 
    
    AHRMM · ahrmm.org 
    
    
    
    ](https://www.ahrmm.org/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Selling a connected device into health systems?

Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Commercialization

Acronym

AKS

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=anti-kickback)

Learn in 60 seconds

Card Lesson Quiz

U.S. criminal statute prohibiting remuneration to induce federal healthcare business.

-   · AKS shapes nearly every MedTech commercial program - physician consulting, training grants, KOL engagement, product loans, GPO contracting. 
-   · Violations carry criminal, civil, and exclusion penalties. 
-   · Safe harbors define protected arrangements. 

Remember this

Watch out: Misinterpreting safe harbor provisions can lead to non-compliance, as strict adherence to all conditions is required for protection.

Related terms

-   [Physician Payments Sunshine Act ](/terms/sunshine-act)
-   [Stark Law ](/terms/stark-law)

You may also need

Auto-suggested from Commercialization and shared keywords.

-   [AdvaMed Code of Ethics ](/terms/advamed-code)
-   [Razor / Razor-Blade Model ](/terms/razor-razorblade)
-   [HIPAA(HIPAA) ](/terms/hipaa)
-   [FedRAMP(FedRAMP) ](/terms/fedramp)
-   [Medhacking ](/terms/medhacking)
-   [SBIR / STTR Grants(SBIR/STTR) ](/terms/sbir-sttr)

[All Commercialization terms](/terms?cat=Commercialization)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)